Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Lv, Zhi Dong ^a   Na, Di ^a   Liu, Fu Nan ^a   Du, Zong Min ^b   Sun, Zhe ^a   Li, Zhen ^a   Ma, Xiao Yang ^a   Wang, Zhen Ning ^a   Xu, Hui Mian ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Engineer of Steelworks of Beiying Iron and Steel Group Co Ltd of Benxi Steel Group Corporation   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; COLLAGEN TYPE 3; EOSIN; FIBRONECTIN; HEMATOXYLIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CELL ADHESION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MESOTHELIUM CELL; PERITONEAL FLUID; PERITONEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; RETROPERITONEAL FIBROSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING; CANCER INVASION; EPITHELIUM; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; PERITONEAL FIBROSIS; PERITONEUM LAVAGE; PERITONEUM TUMOR; PHOSPHORYLATION; STAINING; STOMACH TUMOR; TIME; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; COLLAGEN TYPE III; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; FIBRONECTINS; HUMANS; NEOPLASM INVASIVENESS; PERITONEAL FIBROSIS; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMAD2 PROTEIN; SMAD3 PROTEIN; STAINING AND LABELING; STOMACH NEOPLASMS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77958589001     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-139     Document Type: Article

References (32)

1. Gastric cancer. L Paul M Emad, Br Med Bull 2008 85 87 100 10.1093/bmb/ldn007 18267927
2. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world. F Kamangar GM Dores WF Anderson, J Clin Oncol 2006 24 2137 2150 10.1200/JCO.2005.05.2308 16682732
3. Global cancer statistics 2002. DM Parkin F Bray J Ferlay P Pisani, CA Cancer J Clin 2005 55 74 108 10.3322/canjclin.55.2.74 15761078
4. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: Bestpalliation with a ray of hope for cure. PH Sugarbaker Y Yonemura, Oncology 2000 58 96 107 10.1159/000012086 10705236
5. The distribution of secondary growths in cancer of the breast. S Paget, Lancet 1889 1 571 573 10.1016/S0140-6736(00)49915-0
6. Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer-pooled analysis from three multicenter, randomized, controlled trials using individual patient data. I Chau AR Norman D Cunningham, J Clin Oncol 2004 22 2395 2403 10.1200/JCO.2004.08.154 15197201
7. Fibrosis in the peritoneum induces by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination. M Yashiro YS Chung S Nishimura T Inoue M Sowa, Cancer 1996 77 1668 s1674
8. Mesothelial cells induce the motility of human ovarian carcinoma cells. M Rieppi V Vergani C Gatto G Zanetta P Allavena G Taraboletti R Giavazzi, Int J Cancer 1999 80 303 307 10.1002/(SICI)1097-0215(19990118)80:2<303::AID- IJC21>3.0.CO;2-W 9935214
9. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. N Ahmed C Riley G Rice M Quinn, Clin Exp Met 2005 22 391 402 10.1007/s10585-005-1262-y (Pubitemid 41609298)
10. Transforming growth factor-beta in tissue fibrosis. WA Border NA Noble, N Engl J Med 1994 331 1286 1292 10.1056/NEJM199411103311907 7935686
11. Transforming growth factor-beta: importance in long-term peritoneal membrane changes. PJ Margetts KH Oh M Kolb, Perit Dial Int 2005 25 15 S17 16048248
12. Pathogenesis of fibrosis: role of TGF- and CTGF. L Hironobu, Curr Opin Rheumatol 2002 14 681 68 10.1097/00002281-200211000-00009 12410091
13. High levels of transforming growth factor-1 correlate with disease progression in human colon cancer. E Friedman LI Gold D Klimstra ZS Zeng S Winawer A Cohen, Cancer Epidemiol Biomarker Preven 1995 4 549 554
14. Overexpression of transforming growth factor-1 in scirrhous carcinoma of the stomach correlates with decreased survival. S Kinugasa S Abe M Tachibana, Oncology 1998 55 582 587 10.1159/000011916 9778627
15. An elevated serum level of transforming growth factor-1(TGF-1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma. H Saito S Tsujitani S Oka A Kondo M Ikeguchi M Maeta, Anticancer Res 2000 20 4489 4493 11205293
16. Regulation of TGF- signaling and its roles in progression of tumors. K Miyazono H Suzuki T Imamura, Cancer Sci 2003 94 230 234 10.1111/j.1349-7006. 2003.tb01425.x 12824914
17. Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer. M Tasuku H Kosei Y Masakazu N Shigehiko S Tetsuji S Ikuo S Michio, Clin Exp Met 1998 16 381 388
18. ICAM-1 mediated peritoneal carcinomatosis, a target for therapeutic intervention. NA Alkhamesi P Ziprin K Pfistermuller, Clin Exp Met 2005 22 449 459 10.1007/s10585-005-2893-8 (Pubitemid 41750697)
19. Senescent Peritoneal Mesothelial Cells Promote Ovarian Cancer Cell Adhesion. K Ksiazek J Mikula-Pietrasik K Korybalska, Am J Pathol 2009 174 1231 1240 10.2353/ajpath.2009.080613
20. Interactions between cancer cells and the endothelium in metastasis. FW Orr HH Wang RM Lafrenie S Scherbarth DM Nance, J Pathol 2000 190 310 329 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P 10685065
21. Regulation of melanoma cell migration and invasion by laminin-5 and alpha3beta1 integrin (VLA-3). T Tsuji Y Kawada M Kai-Murozono, Clin Exp Met 2002 19 127 134 10.1023/A:1014573204062 (Pubitemid 34264082)
22. Mesothelial lamellar bodies in norm and experimental conditions. Transmission and scanning electron microscopic observations on the peritoneum, pleura and pericardium. KN Michailova, Anat Embryol (Berl) 2004 208 301 309 15197589
23. Transforming growth factor-beta1 induces epithelial-mesenchymal transition by activating the JNK-Smad3 pathway in rat peritoneal mesothelial cells. Q Liu H Mao J Nie, Peritoneal Dialysis Int 2008 28 88 s95
24. Cytokines and growth factors involved in peritoneal fibrosis of peritoneal dialysis patients. KH Oh PJ Margetts, Int J Artif Organs 2005 28 129 134 15770592
25. Fibronectin in malignancy. RJ Labat, Semin Cancer Biol 2002 12 187 195 10.1016/S1044-579X(02)00022-6 12083849
26. Mechanisms of TGF- signaling from cell membrane to the nucleus. Y Shi J Massague, Cell 2003 113 685 700 10.1016/S0092-8674(03)00432-X 12809600
27. Specificity and versatility in TGF- signaling through Smads. XH Feng R Derynck, Annu Rev Cell Dev Biol 2005 21 659 693 10.1146/annurev.cellbio.21. 022404.142018 16212511
28. The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial to-mesenchymal transition by transforming growth factor- M Tojo Y Hamashima A Hanyu, Cancer Sci 2005 96 791 800 10.1111/j.1349-7006.2005.00103.x 16271073
29. A novel experimental mouse model of peritoneal dissemination of human gastric cancer cells: analysis of the mechanism of peritoneal dissemination using cDNA microarray. H Nomura H Nishimori T Yasoshima, Jpn J Cancer Res 2001 92 748 754 11473725
30. Gene transfer of transforming growth factor-beta1 to the rat peritoneum: effects on membrane function. PJ Margetts M Kolb T Galt CM Hoff TR Shockley J Gauldie, J Am Soc Nephrol 2001 12 2029 2039 11562401
31. The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial monolayers. WM Van Grevenstein LJ Hofland J Jeekel CH van Eijck, Pancreas 2006 32 396 402 10.1097/01.mpa.0000220865.80034.2a 16670622
32. Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3). H Takatsuki S Komatsu R Sano Y Takada T Tsuji, Cancer Res 2004 64 6065 6070 10.1158/0008-5472.CAN-04-0321 15342388